SuperworthCapricor Therapeutics shares outstanding CAPR
Diluted shares outstanding, averaged over each quarter, from 2011.
- Latest quarter, to Jun 30, 2026
- 57.9M
- On a year earlier
- +26.7%
- more shares
Capricor Therapeutics had 57.9M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 26.7% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 48.8M | +10% |
| FY2024 | 44.5M | +45% |
| FY2023 | 30.7M | +22% |
| FY2022 | 25.2M | +4% |
| FY2021 | 24.2M | +19% |
| FY2020 | 20.4M | +370% |
| FY2019 | 4.3M | +40% |
| FY2018 | 3.1M | +6% |
| FY2017 | 2.9M | +37% |
| FY2016 | 2.1M | +32% |
| FY2015 | 1.6M | +39% |
| FY2014 | 1.2M | +7% |
| FY2013 | 1.1M | +1171% |
| FY2012 | 86.1K | +8% |
| FY2011 | 79.4K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 57.9M | +27% | |
| Q1 FY26 | 57.4M | +26% | |
| Q4 FY25 | 48.8M | +10% | |
| Q3 FY25 | 45.7M | +38% | |
| Q2 FY25 | 45.7M | +44% | |
| Q1 FY25 | 45.6M | +46% | |
| Q4 FY24 | 44.5M | +45% | |
| Q3 FY24 | 33.1M | +28% | |
| Q2 FY24 | 31.8M | +26% | |
| Q1 FY24 | 31.4M | +24% | |
| Q4 FY23 | 30.7M | +22% | |
| Q3 FY23 | 25.8M | +6% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Capricor Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.